Home
overview


SMi's Point of Care Diagnostics conference is now in its 7th year - click below to view our 2010 event.

 



2009 Past Event Details:

The demand for point of care testing (POCT) is expected to increase by 80% over the next three years, representing a market of $18.7 billion by 2011.  Yet the challenges facing diagnostic manufacturers over adoption and uptake by clinicians and regulatory approval are still real.

SMi’s 6th annual conference on Point of Care Diagnostics will bring together industry experts and experience clinicians to discuss this exciting area of healthcare technology. Speakers will address the following topics:

  • Emerging and disruptive technologies
  • Clinical needs
  • Connectivity and patient pathways
  • Health service requirements
  • Market trends and dynamics
  • Regulatory affairs and compliance
  • Reimbursement and funding

 

  • GAIN insight into end users’ needs from POCT
  • REVIEW regulatory requirements and compliance strategies for the US and Europe
  • EXAMINE market dynamics and receive key recommendations
  • HEAR case studies of POCT successes

 

Feedback from previous events
"Excellent" - Research Fellow, University of Birmingham
"Very good" - Business Development Manager, Instrumentation Laboratory
"Gave a different perspective to laboratory professionals" - Institute of Biomedical Science
"Interesting topic" - Marketing Manager, Radiometer Medical ApS

  • Chief Scientific Officers
  • Chief Technical Officers
  • Directors/Heads/VPs of Diagnostic Research and Development 
  • Directors/Heads/VPs of Business Development 
  • Directors/Heads/VPs of Point of Care 
  • Hospital CEOs, CIOs, CFOs 
  • Hospital Chief Pathologists / Head of Lab Services
  • Physicians 
  • Pharmacists 
  • Pathologists
  • Clinical Scientists
  • Policy Makers
  • Product/Service Development Manager

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

David Huckle

David Huckle, Chief Executive, Adams Business Associates

9:10 OVERVIEW OF THE POC MARKET

David Huckle

David Huckle, Chief Executive, Adams Business Associates

  • Technology is no longer holding the industry back
  • Need for clinician involvement in development
  • Adoption and economic assessment
  • Future trends
  • 9:50 EXPERIENCES IN POC DEVELOPMENT AND MARKET UPTAKE

    David Watwood

    David Watwood, Sales Director, Inverness Medical UK

  • POC: the early years
  • The POC portfolio
  • Blockers to POC
  • Drivers for POC
  • The future
  • 10:30 Morning Coffee

    11:00 UPTAKE OF DISRUPTIVE TECHNOLOGIES AT THE POC

    Richard Godfrey

    Richard Godfrey, Chief Executive, Balter Medical

  • Economic barriers to adoption
  • Clinician education and training
  • Professional and ethical paradigms
  • Use of market insight
  • Case study: optical diagnosis melanoma
  • 11:40 A FULLY INTEGRATED APPROACH TO POCT

  • Overview of how the introduction of POCT has been approached at the Royal Free
  • Case study 1: management of blood product use in theatres
  • Case study 2: cardiovascular risk stratification in hard to reach populations
     
  • Michael Thomas

    Michael Thomas, Clinical Director of Inflammation Services, Royal Free Hospital

    Susan Mallet

    Susan Mallet, Consultant Anaesthetist, Royal Free Hospital

    Devaki Nair

    Devaki Nair, Consultant Clinical Pathologist, Royal Free Hospital

    12:20 Networking Lunch

    13:50 POCT: CLINICAL NEED AND PATHWAY REDESIGN

    Chris Price

    Chris Price, Visiting Professor in Clinical Biochemistry, University of Oxford

  • Home
  • Primary care
  • Pharmacy and walk-in clinics
  • Hospital
     
  • 14:30 NHS POLICY AND STRATEGY

    Ian Barnes

    Ian Barnes, National Clinical Lead for Pathology, Department of Health

  • Background
  • The Carter and Darzi reviews
  • Transforming pathology
  • Impact of POCT on clinical practice
     
  • 15:10 Afternoon Tea

    15:40 PATIENT PATHWAYS AND CONNECTIVITY

    Fabrizio Mastrantonio

    Fabrizio Mastrantonio, International Marketing Manager, A Menarini Diagnostic

  • Present and future developments
  • POCT connectivity
  • Importance of connectivity
  • Patient empowerment with self-monitoring
  • 16:20 EUROPEAN REGULATORY AFFAIRS AND COMPLIANCE

    Petra Kaars-Wiele

    Petra Kaars-Wiele, Director International Regulatory Affairs and Affiliate Compliance, Abbott Laboratories, Germany

  • Update on current EU regulations
  • Update on relevant international regulations
  • Language requirements for POCT
  • Compliance requirements and consequences of noncompliance
  • 17:00 POC DIAGNOSTICS IN IMPROVING HEALTH SERVICES

    Anthony James

    Anthony James, Technology Adoption Associate, NHS Institute for Innovation and Improvement

  • Creating value for the NHS
  • The real significance of evidence
  • The process of change in the NHS
     
  • 17:40 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Eddie Blair

    Eddie Blair, Director, Integrated Medicines

    9:10 THE USE OF PARAMAGNETIC PARTICLES IN POCT TESTING

    Richard Luxton

    Richard Luxton, Director of the Institute of Bio-Sensing Technology, University Of The West Of England Bristol

  • Overview of paramagnetic particles
  • Magnetic manipulation of particles
  • Detection of magnetic material 
  • 9:50 Diagnostics for the Consumer Market

    Sarah Johnson

    Sarah Johnson, Principal Scientist, Swiss Precision Diagnostics

  • What are consumer diagnostics
  • The current market and how it is changing
  • Case study - pregnancy and ovulation category
    • Evolution of the category
    • How to design for the consumer
    • Selling to consumers
    • Getting it right - a case study on a new consumer diagnostic

       

  • 10:30 Morning Coffee

    11:00 MARKET TRENDS AND DYNAMICS IN POCT

    Harry Glorikian

    Harry Glorikian, Managing Partner, Scientia Advisers

  • Market overview
  • Technology and customer overview
  • Adoption of POC
  • Strategies to maximise access to POCT
  • Key recommendations
  • 11:40 CONNECTIVITY: PAST, PRESENT AND FUTURE

    Jeffrey Du Bois

    Jeffrey Du Bois, Vice President, Medical & Scientific Affairs, Nova Biomedical

  • Why is POCT connectivity important?
  • New connectivity approaches - wireless, internet, and others
  • What's next - POL, mobile clinic, EMS, home?

     

  • 12:20 Networking Lunch

    13:50 REGULATORY AFFAIRS AND COMPLIANCE IN THE US

    Sally Hojvat

    Sally Hojvat, Director, Division of Microbiology Devices, Office of In-Vitro Diagnostic Device Evaluation, FDA

  • Review of US regulations and an update of any recent policy changes 
  • The challenges of regulating newer POC technologies 
  • Adequacy of Quality Control measures and post-market surveillance
     
  • 14:30 POCT AND INFECTIOUS DISEASE

    John Clarkson

    John Clarkson, Chief Executive, Atlas Genetics

  • Target diseases: new and old
  • User requirements
  • Simplifying the technology: making the equipment user friendly
  • Reimbursement issues
  • 15:10 Afternoon Tea

    15:40 THERANOSTICS FOR INFECTIOUS DISEASES

    Till Bachmann

    Till Bachmann, Chief Operating Officer and Head of Biochip Research, University of Edinburgh

  • Targeting the host and the pathogen
  • Antibiotic resistance
  • Novel Technologies
  • 16:20 Chairman’s Closing Remarks and Close of Day One

    Eddie Blair

    Eddie Blair, Director, Integrated Medicines

    +

    Workshops

    How Do We Achieve Concordance Between POCT and Central Lab Tests?
    Workshop

    How Do We Achieve Concordance Between POCT and Central Lab Tests?

    Crowne Plaza - The City
    28th October 2009
    London, United Kingdom

    Crowne Plaza - The City

    19 New Bridge Road
    London EC4V 6DB
    United Kingdom

    Crowne Plaza - The City

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.